Drug Approval Package
-
Singulair
(Montelukast Sodium) Chewable Tablets
Company: Merck & Co., Inc.
Application No.: 20-830/S-008
Approval Date: 3/3/2000
-
Approval Letter(s)(PDF)
-
Printed Labeling(PDF)
-
Medical Review(s)(PDF)
-
Chemistry Review(s)(PDF)
-
Correspondence(PDF)
Date created: September 07, 2001
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-